Wednesday, February 01, 2012

Why science is failing us

Why #science is failing us: #fail On November 30, 2006, executives at Pfizer -- the largest pharmaceutical company in the world -- held a meeting with investors at the firm's research centre in Groton, Connecticut. Jeff Kindler, then the CEO, began the presentation with an upbeat assessment of the company's efforts to bring new drugs to market. He cited "exciting approaches" to the treatment of Alzheimer's disease, fibromyalgia and arthritis. But Kindler was most excited about a new drug called torcetrapib, which had recently entered Phase III clinical trials, the last step before filing for approval. He confidently declared that it would be "one of the most important compounds of our generation".